Amplius Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.51M Buy
1,260
+261
+26% +$267K 0.11% 66
2026
Q1
$919K Sell
999
-28
-3% -$28.4K 0.08% 75
2025
Q4
$1.1M Buy
1,027
+34
+3% +$32.5K 0.09% 68
2025
Q3
$758K Sell
993
-431
-30% -$321K 0.07% 85
2025
Q2
$1.11M Sell
1,424
-122
-8% -$94.8K 0.1% 76
2025
Q1
$1.28M Buy
1,546
+20
+1% +$16.6K 0.13% 66
2024
Q4
$1.18M Buy
1,526
+61
+4% +$50.5K 0.12% 68
2024
Q3
$1.3M Sell
1,465
-7
-0.5% -$6.29K 0.14% 64
2024
Q2
$1.33M Sell
1,472
-27
-2% -$21.6K 0.15% 66
2024
Q1
$1.17M Sell
1,499
-67
-4% -$47.7K 0.13% 68
2023
Q4
$913K Buy
1,566
+1
+0.1% +$584 0.11% 66
2023
Q3
$841K Buy
1,565
+322
+26% +$166K 0.11% 69
2023
Q2
$583K Buy
1,243
+124
+11% +$52K 0.08% 88
2023
Q1
$384K Buy
1,119
+554
+98% +$187K 0.06% 114
2022
Q4
$207K Buy
+565
New +$200K 0.03% 152
2022
Q1
Sell
-654
Closed -$180K 578
2021
Q4
$180K Buy
+654
New +$166K 0.02% 194

Other funds holding LLY

Amplius Wealth Advisors's LLY Position: Q2 2026 in Review

Amplius Wealth Advisors increased its Eli Lilly (LLY) stake by 26% in Q2 2026, buying an estimated $267K and bringing the position to 1,260 shares worth $1.51M. The position accounts for 0.11% of the portfolio, ranked #66.

Amplius Wealth Advisors first reported a position in LLY in Q4 2021 and has held it in 16 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Amplius Wealth Advisors held 1,260 shares of Eli Lilly worth $1.51M as of Q2 2026.
  • Amplius Wealth Advisors bought 261 Eli Lilly shares in Q2 2026, an estimated $267K.
  • Eli Lilly made up 0.11% of Amplius Wealth Advisors's portfolio in Q2 2026, its #66 holding.
  • Amplius Wealth Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 16 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Amplius Wealth Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.